Introduction There is an increasing trend for pharmaceutical companies to partner on common strategic priorities for licensed medicinal products, such as research and development initiatives and establishing a presence in global markets.
← all excerpts
Pharmacovigilance Agreements: Negotiating Safety Data Exchange Timelines: To Agree to Disagree? That is the Question.
1
—
—